WGRX News

Form 8-K

Thunder Rock Capital Serves as Exclusive M&A Advisor to Neuritek Therapeutics, Inc. on $105,000,000 Proposed Acquisition by Wellgistics Health, Inc.

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

Wellgistics Health Inc. 簽署價值 1.05 億美元的意向書，以評估收購 Neuritek Therapeutics, Inc. 的可能性；該公司致力於開發治療神經系統及精神疾病的創新療法

Wellgistics Health firma una carta de intención para evaluar la posible adquisición de Neuritek Therapeutics

Wellgistics Health Inc. unterzeichnet Absichtserklärung über 105.000.000 $ zur Prüfung einer möglichen Übernahme von Neuritek Therapeutics, Inc., einem Pionierunternehmen für innovative Therapien bei neurologischen und psychiatrischen Erkrankungen

Wellgistics Health Inc.签署1.05亿美元意向书，拟评估收购Neuritek Therapeutics, Inc.的可行性，后者致力于开发神经系统及精神疾病的创新疗法

Wellgistics Health Inc., Nörolojik ve Psikiyatrik Bozukluklar İçin Yenilikçi Tedavilere Öncülük Eden Neuritek Therapeutics, Inc.'i Satın Almak Üzere 105 Milyon Dolarlık Niyet Mektubu İmzaladı

Wellgistics Health Inc.签署1.05亿美元意向书，拟评估收购Neuritek Therapeutics, Inc.的可行性，后者致力于开发神经系统及精神疾病的创新疗法

Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share